Seattle, WA, United States of America

Cindy A Sprecher

USPTO Granted Patents = 65 

 

 

Average Co-Inventor Count = 4.6

ph-index = 21

Forward Citations = 1,149(Granted Patents)

Forward Citations (Not Self Cited) = 1,029(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Seattle, WA (US) (1995 - 2012)
  • Patagonia, AZ (US) (2006 - 2012)
  • Hereford, AR (US) (2014)
  • Hereford, AZ (US) (2009 - 2017)
  • Sierra Vista, AZ (US) (2006 - 2019)

Company Filing History:


Years Active: 1995-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cytokine Receptor ZCYTOR17
ZCYTOR17 Ligand Antibodies
Cytokine ZALPHA11 Ligand
Soluble Interleukin-20 Receptor
Polynucleotides Encoding Cytokines
Hematopoietic Cytokine Receptor
ZCYTOR17 Heterodimeric Cytokine
ZALPHA11 Ligand Fusion Proteins
Murine ZCYTOR17 Ligand
Cytokine ZCYTOR17 Ligand Polypeptides
Human Kunitz-Type Inhibitors
Methods of Treating Inflammatory Disease
65 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Cindy A. Sprecher in Cytokine Research**

Introduction

Cindy A. Sprecher is a prominent inventor based in Seattle, Washington, with an impressive portfolio of 65 patents. Her work primarily focuses on the development of novel cytokine receptors that play a crucial role in hematopoietic, lymphoid, and myeloid cell proliferation and development. Sprecher's innovative approaches have significant implications in therapeutic applications for various medical conditions.

Latest Patents

Cindy A. Sprecher's latest patents revolve around the methods of producing zcytor17 heterodimeric cytokine receptors. These patents disclose novel polypeptide combinations and polynucleotides encoding these polypeptides. The inventions also cover methods and compositions related to zcytor17-containing multimeric or heterodimer cytokine receptors, which can be utilized as novel cytokine antagonists. Furthermore, her inventions allow for the detection of ligands that stimulate cell proliferation and development in vitro and in vivo. These patents also encompass methods for producing these multimeric or heterodimeric cytokine receptors, along with their respective uses and antibodies.

Career Highlights

Throughout her career, Cindy Sprecher has made significant contributions to the field of cytokine research, particularly during her tenure at Zymogenetics, Inc. Her extensive work has positioned her as a leading figure in the development of cytokine-based therapies, showcasing her ability to innovate within the realms of biotechnology and pharmaceuticals.

Collaborations

Cindy has collaborated with notable professionals such as Donald C. Foster and Angela K. Hammond. These partnerships have enriched her research endeavors, allowing for a comprehensive approach to understanding and developing cytokine-related treatments.

Conclusion

With 65 patents to her name, Cindy A. Sprecher is a distinguished inventor whose contributions to cytokine research hold great promise for advancing therapeutic methodologies. Her innovative solutions and collaborative efforts continue to influence the medical field profoundly, solidifying her legacy as a pioneer in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…